Revenue: The sum of all revenue fields included for a company's operating activities.
Oncternal Therapeutics, Inc. (ONCT) had Revenue of $0.30M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$0.30M |
$-9.16M |
|
-- |
|
$0.30M |
|
$9.93M |
|
$-9.64M |
|
$0.47M |
|
$-9.16M |
|
$-9.16M |
|
$-9.16M |
|
$-9.16M |
|
$-9.16M |
|
$-9.16M |
|
$-9.64M |
|
$-10.00M |
|
2.94M |
|
2.94M |
|
$-3.03 |
|
$-3.03 |
|
| Balance Sheet Financials | |
$36.06M |
|
-- |
|
$0.67M |
|
$36.73M |
|
$5.20M |
|
-- |
|
$1.48M |
|
$6.68M |
|
$30.05M |
|
$30.05M |
|
$30.05M |
|
2.95M |
|
| Cash Flow Statement Financials | |
$-32.16M |
|
$0.65M |
|
$1.07M |
|
$37.14M |
|
$6.70M |
|
$-30.45M |
|
$7.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3244.44% |
|
-3244.45% |
|
-- |
|
-3085.52% |
|
-3085.52% |
|
$-32.16M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-30.49% |
|
-30.49% |
|
-24.95% |
|
-30.49% |
|
$10.19 |
|
$-10.94 |
|
$-10.94 |
|